Clinical Trial Update: RELOVAIR® Lung Deflation Study [Phase 3]

View source ↗

Summary

Phase 3 trial update showing results for RELOVAIR Lung Deflation Study in chronic obstructive pulmonary disease; study completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• RELOVAIR

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2015-04-07